NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

KemPharm Inc (NASDAQ: KMPH)

 
KMPH Technical Analysis
5
As on 3rd May 2023 KMPH STOCK Price closed @ 4.97 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 6.02 & Strong Sell for SHORT-TERM with Stoploss of 8.26 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

KMPHSTOCK Price

Open 5.10 Change Price %
High 5.14 1 Day 0.03 0.61
Low 4.85 1 Week -0.89 -15.19
Close 4.97 1 Month 0.17 3.54
Volume 289386 1 Year -4.13 -45.38
52 Week High 9.37 | 52 Week Low 4.02
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
KMPH
Daily Charts
KMPH
Intraday Charts
Whats New @
Bazaartrend
KMPH
Free Analysis
 
KMPH Important Levels Intraday
RESISTANCE5.53
RESISTANCE5.35
RESISTANCE5.24
RESISTANCE5.13
SUPPORT4.81
SUPPORT4.70
SUPPORT4.59
SUPPORT4.41
 
KMPH Forecast April 2024
4th UP Forecast9.17
3rd UP Forecast7.82
2nd UP Forecast6.99
1st UP Forecast6.16
1st DOWN Forecast3.78
2nd DOWN Forecast2.95
3rd DOWN Forecast2.12
4th DOWN Forecast0.77
 
KMPH Weekly Forecast
4th UP Forecast7.55
3rd UP Forecast6.72
2nd UP Forecast6.21
1st UP Forecast5.70
1st DOWN Forecast4.24
2nd DOWN Forecast3.73
3rd DOWN Forecast3.22
4th DOWN Forecast2.39
 
KMPH Forecast2024
4th UP Forecast15.93
3rd UP Forecast12.42
2nd UP Forecast10.24
1st UP Forecast8.07
1st DOWN Forecast1.87
2nd DOWN Forecast-0.3
3rd DOWN Forecast-2.48
4th DOWN Forecast-5.99
 
 
KMPH Other Details
Segment EQ
Market Capital 353294688.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
KMPH Address
KMPH
 
KMPH Latest News
 
Your Comments and Response on KemPharm Inc
 
KMPH Business Profile
KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds that may have applications for new disease indications. Its prodrug product candidate pipeline is focused on the high need areas of attention deficit hyperactivity disorder, stimulant use disorder, and CNS rare diseases, including idiopathic hypersomnia. KemPharm's lead clinical development candidate for the treatment of stimulant use disorder, KP879, is based on its prodrug of d-methylphenidate, known as serdexmethylphnidate. In addition, the company has received FDA approval for AZSTARYS, a new once-daily treatment for attention deficit hyperactivity disorder in patents age six years and older, and for APADAZ, an immediate-release combination product containing benzhydrocodone, a prodrug of hydrocodone, and acetaminophen. KemPharm, Inc. has collaboration and license agreement, with KVK-Tech, Inc. The company was incorporated in 2006 and is headquartered in Celebration, Florida. Address: 1180 Celebration Boulevard, Celebration, FL, United States, 34747
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service